SLB
55
2
ITW
52
2
AAPL
65
3
SE
82
3
T
68
2
F
48
6
ECL
72
2
IP
53
5
TSN
44
-2
ES
41
-2
MPC
44
5
NKE
39
2
LB
53
3
K
65
2
MCK
63
-3
ADT
38
3
PDCO
63
2
SIG
49
15
PAYX
44
-6
FIS
53
2
SLB
55
2
ITW
52
2
AAPL
65
3
SE
82
3
T
68
2
F
48
6
ECL
72
2
IP
53
5
TSN
44
-2
ES
41
-2
MPC
44
5
NKE
39
2
LB
53
3
K
65
2
MCK
63
-3
ADT
38
3
PDCO
63
2
SIG
49
15
PAYX
44
-6
FIS
53
2
Financhill
Back

BNY Mellon Innovators ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
90

BKIV
BNY Mellon Innovators ETF

Last Price:
$37.97
Seasonality Move:
0.04%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Buy
90
BNY Mellon Innovators ETF (BKIV) is a Buy

Is BNY Mellon Innovators ETF a Buy, Sell or Hold?

  • The current BNY Mellon Innovators ETF [BKIV] share price is $37.97. The Score for BKIV is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • BKIV is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKIV Stock Price Chart

What is BNY Mellon Innovators ETF's stock price today?

  • The BNY Mellon Innovators ETF share price today is $37.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BKIV is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BKIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.34 Buy
Relative Strength Index (14 RSI): 57.6 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.46 - 38.16) Buy
Bollinger Bands (100): (34.05 - 37.47) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

BKIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.94 Buy
20-day SMA: 37.64 Buy
50-day SMA: 37.08 Buy
200-day SMA: 33.98 Buy
8-day EMA: 37.88 Buy
20-day EMA: 37.57 Buy
50-day EMA: 36.92 Buy
200-day EMA: 34.19 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

BNY Mellon Innovators ETF Earnings Growth & BKIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

BNY Mellon Innovators ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):